Explore more publications!

LATAM News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM News Online.

Press releases published on October 27, 2025

Curia invierte 4 millones de dólares para mejorar la fabricación de APIs estériles
Curia, 무균 API 제조 역량 강화 위해 400만 달러 투자
Curia Invests $4 Million to Enhance Sterile API Manufacturing
Curia investiert 4 Mio. US-Dollar in die Optimierung der Herstellung steriler Wirkstoffe
Curia Melabur AS$4 Juta untuk Mempertingkat Pengeluaran API Steril
Curia ลงทุน 4 ล้านดอลลาร์เพื่อยกระดับการผลิต Sterile API
Curia 投資 400 萬美元增強無菌有效藥劑成分的製造
Curia משקיעה 4 מיליון דולר לשיפור ייצור API סטרילי
Curia Berinvestasi $4 Juta untuk Meningkatkan Mutu Manufaktur API Steril
Curia 投资 400 万美元改进无菌原料药(API)的制造
Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial
RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p.m. ET
SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $31 Million in Gross Proceeds
Creative Medical Technology Holdings Issues Letter to Shareholders
Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches
Maxus Mining Reports on Exploration Insights at the Lotto Project in British Columbia
Cocrystal Pharma Receives NIH SBIR Award to Advance its Influenza Inhibitor Program
Centers for Medicare and Medicaid Services Assigns Permanent J Code for ZUSDURI™ Effective January 1, 2026
AlphaTON (Nasdaq:ATON) and Cyncado Therapeutics: Preclinical Mesothelioma Data Show Direct A2B Tumor Activity; TT-4 Achieved >90% Tumor Growth Inhibition; First-Patient Dosing on Track for Q1 2026
Revolution Medicines’ RAS(ON) Multi-Selective Inhibitor Daraxonrasib Granted U.S. FDA Orphan Drug Designation in Pancreatic Cancer

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions